KaydedilenlerDerginizi ekleyin

Dergiler / European Journal of Biology / 2023 / Volume: 82 Issue: 2

Measurement of Total Iron in Breast Tissue Samples by Inductively Coupled Plasma-Mass Spectrometry

Mete Bora Tüzüner(Acibadem Labmed Clinical Laboratories, Research and Development Center)0000-0001-8924-4850
Burcin Tüzüner(Istanbul Gelisim University, Department of Basic Medical Sciences, Biochemistry, Faculty of Dentistry)0000-0001-5122-4977
Sayfa
—
Yayın Tarihi
2023-12-21
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Understanding the relationship between tissue iron levels and tumor characteristics is essential in identifying potential prevention and treatment strategies.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Breast cancer is the commonest and the deadliest malignancy among women.
📊
Temel Bulgular & Veri:Materials and Methods: Iron contents were determined in 25 tissue sets (matched tumor and peritumoral tissues) collected from 25 women diagnosed with invasive ductal breast cancer.
💡
Sonuç & Katkı:Understanding the relationship between tissue iron levels and tumor characteristics is essential in identifying potential prevention and treatment strategies.
🔬Tür:Research Article
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Iron · Breast cancer · ROS

Abstract

Objective: Breast cancer is the commonest and the deadliest malignancy among women. Iron is known as an essential element for cell growth and division. The connection between oxidative stress, antioxidants, and progression, aggressiveness, and recurrence of breast cancer, is widely recognized to involve impaired iron metabolism. The purpose of this study was to investigate the connection between the tumor characteristics and the levels of total iron in breast tissues by employing state of the art technology, inductively-coupled plasma/mass spectrometry (ICP-MS) with our in-house analysis methodology for tissue samples. Materials and Methods: Iron contents were determined in 25 tissue sets (matched tumor and peritumoral tissues) collected from 25 women diagnosed with invasive ductal breast cancer. In addition, three cancer-free breast tissues, obtained from breast reduction surgery, were analyzed as a normal group. Collected samples were digested and introduced to ICP-MS for iron analysis. Results: Our method showed a low rate of measurement error (<10%). A highly significant (p<0.001) ∼3 fold difference of iron concentrations were observed in tumors (24.73±6.15 ppb/mg) as compared to peritumoral tissues (9.10±4.84 ppb/mg). As the grade and stage of the cancer increases, iron levels in tumor tissues were also found to be increased (p=0.006, p=0.022 respectively). Conclusion: Our ICP-MS based method can be reliably performed at the established conditions for tissue specimens, and also have potential to be used in clinical practice. Understanding the relationship between tissue iron levels and tumor characteristics is essential in identifying potential prevention and treatment strategies.

🔖

Bu Makaleye Atıf Yap

Tüzüner, M. B., Tüzüner, B. (2023). Measurement of Total Iron in Breast Tissue Samples by Inductively Coupled Plasma-Mass Spectrometry. European Journal of Biology, Volume: 82 Issue: 2. https://doi.org/10.26650/EurJBiol.2023.1313209

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (68)

  1. Wilkinson L, Gathani T. Understanding breast cancer as a global health concern. Br J Radiol. 2022;95(1130): 20211033. doi:10.1259/bjr.20211033. google scholar
  2. Guo Q, Li L, Hou S, et al. The role of iron in cancer progression. Front Oncol. 2021;11:778492. doi: 10.3389/fonc.2021.778492. google scholar
  3. Thompson HJ, Kennedy K, Witt M, Juzefyk J. Effect of di-etary iron deficiency or excess on the induction of mam-mary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis. 1991;12:111-114. google scholar
  4. Singh M, Lu J, Briggs SP, McGinley JN, Haegele AD, Thompson HJ. Effect of excess dietary iron on the promotion stage of 1-methyl-1-nitrosourea-induced mammary carcinogenesis: patho-genetic characteristics and distribution of iron. Carcinogenesis. 1994;15:1567-1570. google scholar
  5. Hrabinski D, Hertz JL, Tantillo C, Berger V, Sherman AR. Iron repletion attenuates the protective effects of iron defi-ciency in DMBA-induced mammary tumors in rats. Nutr Cancer. 1995;24:133-142. google scholar
  6. Diwan BA, Kasprzak KS, Anderson LM. Promotion of dimethylbenz[a]anthracene-initiated mammary carcinogenesis by iron in female Sprague-Dawley rats. Carcinogenesis. 1997;18:1757-1762. google scholar
  7. Huang X. Does iron have a role in breast cancer? Lancet Oncol. 2008;9:803-807. google scholar
  8. Cui Y, Vogt S, Olson N, Glass AG, Rohan TE. Levels of zinc, selenium, calcium, and iron in benign breast tissue and risk of subsequent breast cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:1682-1685. google scholar
  9. Elliott RL, Elliott MC, Wang F, Head JF. Breast carcinoma and the role of iron metabolism. A cytochemical, tissue culture, and ultrastructural study. Ann N Y Acad Sci. 1993;698:159-166. google scholar
  10. Miller LD, Coffman LG, Chou JW, et al. An iron regulatory gene signature predicts outcome in breast cancer. Cancer Res. 2011;71:6728-6737. google scholar
  11. Shpyleva SI, Tryndyak VP, Kovalchuk O, et al. Role of ferritin alterations in human breast cancer cells. Breast Cancer Res Treat. 2011;126:63-71. google scholar
  12. Toyokuni S. Iron-induced carcinogenesis: The role of redox reg-ulation. Free Radic Biol Med. 1996;20(4):553-566. google scholar
  13. Nelson RL. Dietary iron and colorectal cancer risk. Free Radic Biol Med. 1992;12(2):161-168. google scholar
  14. Eaton JW, Qian M. Molecular bases of cellular iron toxicity. Free Radic Biol Med. 2002;32(9):833-840. google scholar
  15. Benhar M, Engelberg D, Levitzki A. ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep. 2002;3(5):420-425. google scholar
  16. Kowdley KV. Iron, hemochromatosis, and hepatocellular carci-noma. Gastroenterology. 2004;127(5 Suppl 1):S79-86. google scholar
  17. Galaris D, Skiada V, Barbouti A. Redox signaling and cancer: the role of “labile” iron. Cancer Lett. 2008;266(1):21-29. google scholar
  18. Cermak J, Balla J, Jacob HS, et al. Tumor cell heme uptake induces ferritin synthesis resulting in altered oxidant sensitivity: possible role in chemotherapy efficacy. Cancer Res. 1993;53(21):5308-5313. google scholar
  19. Omary MB, Trowbridge IS, Minowada J. Human cell-surface gly-coprotein with unusual properties. Nature. 1980:286(5776):888-891. google scholar
  20. Brookes MJ, Hughes S, Turner FE, et al. Modulation of iron transport proteins in human colorectal carcinogenesis. Gut. 2006;55(10):1449-1460. google scholar
  21. Boult J, Roberts K, Brookes MJ, et al. Overexpression of cellular iron import proteins is associated with malignant progression of esophageal adenocarcinoma. Clin. Cancer Res.2008;14(2):379-387. google scholar
  22. Gulcin İ. Antioxidants and antioxidant methods: An updated overview. Arch Toxicol. 2020;94:651-715. google scholar
  23. Khurana RK, Jain A, Jain A, Sharma T, Singh B, Kesharwani P. Administration of antioxidants in cancer: Debate of the decade. Drug Discov Today. 2018;23:763-770. google scholar
  24. Athreya K, Xavier MF. Antioxidants in the treatment of cancer. Nutr Cancer. 2017;69: 1099-1104. google scholar
  25. Sarmiento-Salinas FL, Delgado-Magallon A, Cortes-Hernandez P, Reyes-Leyva J, Herrera-Camacho I. Breast cancer subtypes present a differential production of reactive oxygen species (ROS) and susceptibility to antioxidant treatment. Front Oncol. 2019;9:1-13. doi: 10.3389/fonc.2019.00480. google scholar
  26. Gill JG, Piskounova E, Morrison SJ. Cancer, oxidative stress, and metastasis. Cold Spring Harb Symp Quant Biol. 2016;81:163-175. google scholar
  27. Satheesh NJ, Samuel SM, Büsselberg D. Combination therapy with vitamin C could eradicate cancer stem cells. Biomolecules. 2020;10:79. doi: 10.3390/biom10010079. google scholar
  28. Mohsin AR, Khan UH, Akbar B. Evaluation of post radiotherapy antioxidants levels in cancer patients. Asian J Multidiscip Stud. 2019;7:2348-7186. google scholar
  29. Jung AY, Cai X, Thoene K, et al. Antioxidant supplementa-tion and breast cancer prognosis in postmenopausal women un-dergoing chemotherapy and radiation therapy. Am J Clin Nutr. 2019;109:69-78. google scholar
  30. Dastmalchi N, Baradaran B, Latifi-Navid S, et al. Antioxidants with two faces toward cancer. Life Sci. 2020;258:118186. doi: 10.1016/j.lfs.2020.118186. google scholar
  31. Bonner MY, Arbiser JL. The antioxidant paradox: What are an-tioxidants and how should they be used in a therapeutic context for cancer. Future Med Chem. 2014; 6:1413-1422. google scholar
  32. Ambrosone, C.B. Review article oxidants and antioxidants in breast cancer. Antioxid Redox Signal. 2000;2:903-917. google scholar
  33. Zacharski LR, Ornstein DL, Woloshin S, Schwartz LM. Associa-tion of age, sex, and race with body iron stores in adults: Analysis of NHANES III data. Am Heart J. 2000;140(1):98-104. google scholar
  34. Valko M, Rhodes CJ, Moncol J, Izakovic M, Mazur M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chem Biol Interact. 2006;160(1):1-40. doi: 10.1016/j.cbi.2005.12.009. google scholar
  35. Whitmire M, Osredkar A, Ammerman J, et al. Full validation of a high resolution ICP-MS bioanalysis method for iron in hu-man plasma with K2EDTA. J Chromatograph Separat Techniq. 2011;S4:001. doi:10.4172/2157-7064.S4-001. google scholar
  36. An introduction to the fundamentals of inductively cou-pled plasma-mass spectrometry (ICP-MS) facts. Agi-lent website. https://www.agilent.com/en/product/atomic-spectroscopy/inductively-coupled-plasma-mass-spectrometry-icp-ms/what-is-icp-ms-icp-ms-faqs. Accessed June 8, 2023. google scholar
  37. Badran M, Morsy R, Soliman H, Elnimr T. Assessment of wet acid digestion methods for ICP-MS determination of trace elements in biological samples by using Multivariate Statistical Analysis. J Elem. 2018;23(1):179-189. google scholar
  38. Imam MU, Zhang S, Ma J, Wang H, Wang F. Antioxidants mediate both iron homeostasis and oxidative stress. Nutrients. 2017;9(7): 671. doi: 10.3390/nu9070671. google scholar
  39. Mertz W. The essential trace elements. Science.1981;213(4514):1332-1338. google scholar
  40. Malakar R, Kour M, Ahmed A, Malviya SN, Dangi CBS. Trace elements ratio in patients of haemoglobinopathie. Int J Curr Mi-crobiol App Sci. 2014;3(6):81-92. google scholar
  41. Marjania A, kbari FA, Eshghinia S. Association between trace elements and metabolic syndrome among type 2 diabetes mellitus patients in Gorgan. Asian J Pharm Clin Res. 2015;8(3): 358-363. google scholar
  42. Badran M, Morsy R, Soliman H, Elnimr T. Assessment of trace elements levels in patients with Type 2 diabetes using Multivariate Statistical Analysis. J Trace Elem Med Bio. 2016;33:114-119. google scholar
  43. Iyengar VG, Subramanian KS, Joost RW. Element Analysis of Biological Samples, Principles and Practice. 1st ed. Woittiez, Boca Raton.;FL:CRC Press. 1998:137. google scholar
  44. Becker JS, Dietze HJ. State-of-the-art in inorganic mass spectrom-etry for analysis of high-purity materials. Int J Mass Spectrom. 2003;228(2):127-150. google scholar
  45. McComb JQ, Rogers C, Han FX, Tchounwou PB. Rapid screen-ing of heavy metals and trace elements in environmental sam-ples using portable X-ray fluorescence spectrometer, A com-parative study. Water Air Soil Pollut. 2014;225(12):1-10. doi: 10.1007/s11270-014-2169-5. google scholar
  46. Dressler VL,Antes FG, Moreira CM, Pozebon D, Andrei Duarte F. As, Hg, I, Sb, Se and Sn speciation in body fluids and bio-logical tissues using hyphenated-ICP-MS techniques. Int J Mass Spectrom. 2011;307(1-3):149-162. google scholar
  47. Enders A, Lehmann J. Comparison of wet digestion and dry ashing methods for total elemental analysis of biochar. Commun Soil Sci Plant Anal. 2012;43(4): 1042-1052. google scholar
  48. Vanhoe H. A review of the capabilities of ICP-MS for trace element analysis in body fluids and tissues. J Trace Elem Electrolytes Health Dis. 1993;7(3):131-139. google scholar
  49. Takahashi SI, Takahashi H. Sato, Kubota Y, Yoshida S, Mura-matsu Y. Determination of major and trace elements in the liver of Wistar rats by inductively coupled plasma-atomic emission spectrometry and mass spectrometry. Lab Animal. 2000;34(1): 97-105. google scholar
  50. Hseu ZY. Evaluating heavy metal contents in nine composts using four digestion methods. Biores Technol. 2004;95(1): 53-59. google scholar
  51. Hansen THK, Laursen H, Persson DP, Pedas P, Husted S, Schjo-erring JK. Microscaled high-throughput digestion of plant tissue samples for multi-elemental analysis. Plant Methods. 2009;5(1): 5-12. google scholar
  52. Liu M, Okada S. Induction of free radicals and tumors in the kidney of Wistar rats by ferric ethylendiaminbe-N,N’-diacetate. Int J Sports Med. 1996;17: 397-403. google scholar
  53. Mello FA, Meneghini R. In vivo formation of single-strand breaks in DNA by hydrogen peroxide is mediated by the Haber-Weissreaction. Biochem Biophys Acta. 1984;781: 56-63. google scholar
  54. Okada S. Iron-induced tissue damage and cancer: The role of re-active oxygen species and free radicals. Pathol Int. 1996;46:311-332. google scholar
  55. Weinberg ED. The role of iron in cancer. Eur J Cancer Prev. 1996;5: 19-36. google scholar
  56. Ionescu JG, Novotny J, Stejskal V, Latsch A, Blaurock-Busch E, Eisenmann-Klein M. Increased levels of transition metals in breast cancer tissue. Neuro Endocrinol Lett. 2006;27 (Suppl. 1):36-39. google scholar
  57. Marques O, Porto G, Rema A, et al. Local iron homeostasis in the breast ductal carcinoma microenvironment. BMC cancer. 2016;16(1):1-14. doi: 10.1186/s12885-016-2228-y. google scholar
  58. Sharma M, Beck AH, Webster JA, et al. Analysis of stromal signatures in the tumor microenvironment of ductal carcinoma in situ. Breast Cancer Res Treat. 2010;123:397-404. google scholar
  59. Ma XJ, Dahiya S, Richardson E, Erlander M, Sgroi DC. Gene expression profiling of the tumor microenvironment during breast cancer progression. Breast Cancer Res. 2009;11:R7. doi: 10.1186/bcr2222. google scholar
  60. Pinnix ZK, Miller LD, Wang W, et al. Ferroportin and iron regu-lation in breast cancer progression and prognosis. Sci Transl Med. 2010;2(43):43ra56. doi: 10.1126/scitranslmed.3001127. google scholar
  61. Kwok JC, Richardson DR. The iron metabolism of neoplastic cells: alterations that facilitate proliferation?. Crit Rev Oncol Hematol. 2002;42(1):65-78. google scholar
  62. Tuzuner MB, Ozturk T, Ilvan S, et al. Local aromatase activ-ity alterations in breast cancer tissues: A potential way of de-cision support for clinicians. Exp Mol Pathol.2021;118:104574. doi: 10.1016/j.yexmp.2020.104574. google scholar
  63. Simpson ER. Sources of estrogen and their importance. J Steroid Biochem Mol Biol. 2003; 86(3-5):225-230. google scholar
  64. Lonning PE, Haynes BP, Straume AH, et al. Recent data on intra-tumor estrogens in breast cancer. Steroids. 2011;76(8):786-791. google scholar
  65. Bajbouj K, Shafarin J, Abdalla MY, Ahmad I, Hamad M. Estrogen-induced disruption of intracellular iron metabolism leads to oxidative stress, membrane damage, and cell cy-cle arrest in MCF-7 cells. Tumor Biol. 2017;39:1-12. doi: 10.1177/1010428317726184. google scholar
  66. Cavalieri E, Chakravarti D, Guttenplan J, et al. Catechol estrogen quinones as initiators of breast and other human cancers: Impli-cations for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta. 2006;1766:63-78. google scholar
  67. Jian J, Yang Q, Dai J, et al. Effects of iron deficiency and iron overload on angiogenesis and oxidative stress—A potential dual role for iron in breast cancer. Free Radic Biol Med. 2011;50: 841-847. google scholar
  68. Vanhoe H. A review of the capabilities of ICP-MS for trace element analysis in body fluids and tissues. J Trace Elem Electrolytes Health Dis. 1993;7(3):131-139. google scholar